{"log_id": 6376250996778083033, "direction": 0, "words_result_num": 43, "words_result": [{"probability": {"variance": 0, "average": 0.999812, "min": 0.999812}, "location": {"width": 24, "top": 191, "height": 28, "left": 1093}, "words": "文"}, {"probability": {"variance": 0.000786, "average": 0.990591, "min": 0.885982}, "location": {"width": 315, "top": 262, "height": 48, "left": 133}, "words": "良反应轻微而短暂,不需终止治疗"}, {"probability": {"variance": 0.004538, "average": 0.981092, "min": 0.591732}, "location": {"width": 775, "top": 316, "height": 73, "left": 180}, "words": "对本品任一组份过敏者,或以前曾用某一血管紧张素转换酶抑制剂治疗发生血管神经性"}, {"probability": {"variance": 0.009516, "average": 0.943521, "min": 0.774557}, "location": {"width": 71, "top": 319, "height": 26, "left": 145}, "words": "【禁忌】"}, {"probability": {"variance": 0.000132, "average": 0.995001, "min": 0.937414}, "location": {"width": 620, "top": 369, "height": 61, "left": 141}, "words": "水肿的病人,以及遗传性或自发性血管神经性水肿的病人,禁用本品"}, {"probability": {"variance": 7e-06, "average": 0.998204, "min": 0.990885}, "location": {"width": 213, "top": 429, "height": 39, "left": 184}, "words": "肾功能严重受损者慎用"}, {"probability": {"variance": 0.000123, "average": 0.992955, "min": 0.968698}, "location": {"width": 111, "top": 479, "height": 27, "left": 153}, "words": "【注意事项】"}, {"probability": {"variance": 5.5e-05, "average": 0.9948, "min": 0.977757}, "location": {"width": 150, "top": 513, "height": 31, "left": 190}, "words": "马来酸依那普利"}, {"probability": {"variance": 5e-06, "average": 0.998352, "min": 0.994543}, "location": {"width": 125, "top": 553, "height": 30, "left": 223}, "words": "症状性低血压"}, {"probability": {"variance": 0.001047, "average": 0.991003, "min": 0.796171}, "location": {"width": 775, "top": 557, "height": 71, "left": 192}, "words": "极少发生于无并发症的高血压病人。服用马来酸依那普利的高血压病人,由于利尿剂的"}, {"probability": {"variance": 6e-05, "average": 0.995695, "min": 0.965574}, "location": {"width": 817, "top": 597, "height": 72, "left": 154}, "words": "治疗、饮食限盐、透析、腹泻或呕吐等而致血容量不足,则较有可能发生低血压(请参阅药"}, {"probability": {"variance": 0.0018, "average": 0.987804, "min": 0.730467}, "location": {"width": 817, "top": 637, "height": 72, "left": 155}, "words": "物相互作用和不良反应)。在心衰病人中,曾观察到症状性低血压的发生,心衰程度较重的"}, {"probability": {"variance": 0.000956, "average": 0.986904, "min": 0.841314}, "location": {"width": 816, "top": 678, "height": 70, "left": 157}, "words": "病人,发生的可能性最大。这类病人应在医疗监测下开始治疗,每当调整马来酸依那普利或"}, {"probability": {"variance": 0.000212, "average": 0.992773, "min": 0.932333}, "location": {"width": 814, "top": 718, "height": 71, "left": 160}, "words": "/和利尿剂的剂量时,都应密切随访观察。同样的处理也适用于患缺血性心脏病或脑血管病"}, {"probability": {"variance": 2.4e-05, "average": 0.996618, "min": 0.981137}, "location": {"width": 722, "top": 764, "height": 65, "left": 161}, "words": "的病人,因为在这些病人中血压下降过多可能导致心肌梗塞或脑血管意外的发生"}, {"probability": {"variance": 7.2e-05, "average": 0.994413, "min": 0.958061}, "location": {"width": 776, "top": 798, "height": 69, "left": 203}, "words": "如果出现低血压,病人应仰卧,必要时静脉输注生理盐水。短暂性低血压反应并不是继"}, {"probability": {"variance": 0.000244, "average": 0.991705, "min": 0.930732}, "location": {"width": 598, "top": 851, "height": 57, "left": 165}, "words": "续用药的禁忌症。通常在扩充血容量后,一旦血压上升,便可给药"}, {"probability": {"variance": 0.000348, "average": 0.991808, "min": 0.90018}, "location": {"width": 770, "top": 881, "height": 64, "left": 210}, "words": "一些血压正常或偏低的心衰病人,服用后可能出现全身血压进一步下降,如出现低血压"}, {"probability": {"variance": 0.009539, "average": 0.967616, "min": 0.563265}, "location": {"width": 516, "top": 936, "height": 51, "left": 169}, "words": "症状,则有必要减少剂量和/或停止使用利尿剂和/或本品"}, {"probability": {"variance": 0.00029, "average": 0.990556, "min": 0.935056}, "location": {"width": 297, "top": 985, "height": 40, "left": 208}, "words": "2.主动脉瓣狭窄/肥厚型心脏病"}, {"probability": {"variance": 4.5e-05, "average": 0.995795, "min": 0.969515}, "location": {"width": 619, "top": 1010, "height": 56, "left": 213}, "words": "血管紧张素转换酶抑制剂用于左心室流出道梗塞的病人时,应该谨慎"}, {"probability": {"variance": 2.8e-05, "average": 0.99542, "min": 0.98669}, "location": {"width": 138, "top": 1074, "height": 28, "left": 214}, "words": "3.肾功能不全"}, {"probability": {"variance": 1.4e-05, "average": 0.997014, "min": 0.984756}, "location": {"width": 435, "top": 1099, "height": 45, "left": 215}, "words": "用血管紧张素转换酶抑制剂开始治疗后发生的低"}, {"probability": {"variance": 0.000554, "average": 0.985646, "min": 0.921921}, "location": {"width": 301, "top": 1075, "height": 48, "left": 690}, "words": "一些病人的肾功能进一步受"}, {"probability": {"variance": 0.01311, "average": 0.946617, "min": 0.558239}, "location": {"width": 377, "top": 1141, "height": 45, "left": 176}, "words": "到某些损伤。已有报道这种情况引起急性"}, {"probability": {"variance": 0.005585, "average": 0.964713, "min": 0.759389}, "location": {"width": 212, "top": 1129, "height": 31, "left": 638}, "words": "但通常都是可逆的。"}, {"probability": {"variance": 0.012336, "average": 0.960171, "min": 0.45585}, "location": {"width": 777, "top": 1161, "height": 64, "left": 217}, "words": "肾功能不全的病人可能需要减少剂量和药的次数(请参阅剂量和用法)。一些"}, {"probability": {"variance": 0.002742, "average": 0.974725, "min": 0.697491}, "location": {"width": 816, "top": 1201, "height": 65, "left": 179}, "words": "双侧肾动脉狭窄或独肾且肾动腺狭窄的病人,曾出现血尿素氮和血清肌酐增高,通常停止治"}, {"probability": {"variance": 0.019444, "average": 0.951537, "min": 0.383632}, "location": {"width": 419, "top": 1255, "height": 54, "left": 179}, "words": "疗可获逆转;对于肾功能不全的人更如此"}, {"probability": {"variance": 0.006471, "average": 0.977304, "min": 0.512374}, "location": {"width": 772, "top": 1284, "height": 62, "left": 223}, "words": "某些以前没有明显肾脏疾痛的病当同时使用马来酸依那普利和利尿剂时,通常有轻"}, {"probability": {"variance": 0.004152, "average": 0.972698, "min": 0.692232}, "location": {"width": 848, "top": 1313, "height": 77, "left": 183}, "words": "度或一过性血尿素氮和血清肌酐升高,可能需要减少剂量和/或停用利尿剂和或马米酸依那有"}, {"probability": {"variance": 0, "average": 0.968299, "min": 0.968299}, "location": {"width": 34, "top": 1317, "height": 38, "left": 1025}, "words": "限"}, {"probability": {"variance": 0, "average": 0.904047, "min": 0.904047}, "location": {"width": 34, "top": 1365, "height": 30, "left": 1081}, "words": "少"}, {"probability": {"variance": 1e-06, "average": 0.996156, "min": 0.995284}, "location": {"width": 46, "top": 1397, "height": 24, "left": 184}, "words": "普利"}, {"probability": {"variance": 0.000173, "average": 0.99492, "min": 0.953499}, "location": {"width": 260, "top": 1425, "height": 36, "left": 256}, "words": "过敏性/血管神经性水肿"}, {"probability": {"variance": 0.020132, "average": 0.944776, "min": 0.456241}, "location": {"width": 820, "top": 1449, "height": 56, "left": 223}, "words": "据报道,使用血管紧张素转换酶抑制剂的病人,偶有报告发生面部、四肢、屑、苦、声管"}, {"probability": {"variance": 3e-06, "average": 0.995953, "min": 0.993928}, "location": {"width": 111, "top": 1392, "height": 88, "left": 1024}, "words": "理专用章"}, {"probability": {"variance": 0.038849, "average": 0.663411, "min": 0.466308}, "location": {"width": 84, "top": 1462, "height": 42, "left": 996}, "words": "(5"}, {"probability": {"variance": 0.002062, "average": 0.980717, "min": 0.778943}, "location": {"width": 814, "top": 1489, "height": 53, "left": 186}, "words": "门和/或喉的血管神经性水肿者。可在治疗期的任何时间发生。这时应立即停用本品,并给"}, {"probability": {"variance": 0.011896, "average": 0.960779, "min": 0.491098}, "location": {"width": 704, "top": 1534, "height": 46, "left": 185}, "words": "予适当的监护,以保证病人出院之前症状完全消退。当肿胀局限于面、唇部位时"}, {"probability": {"variance": 6e-06, "average": 0.997727, "min": 0.992414}, "location": {"width": 141, "top": 1531, "height": 27, "left": 859}, "words": "位时,一般可以"}, {"probability": {"variance": 0.000206, "average": 0.994793, "min": 0.92996}, "location": {"width": 456, "top": 1581, "height": 39, "left": 186}, "words": "不经治疗而消失。抗组织胺药物对解除症状很有用"}, {"probability": {"variance": 0.022547, "average": 0.859029, "min": 0.627443}, "location": {"width": 104, "top": 1607, "height": 37, "left": 1070}, "words": "仅供存档"}], "language": 3}